Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETC-1002 vs placebo in hypercholesterolemia (Japan, multicenter RCT)
jRCT2031200445Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bempedoic acid in hypercholesterolemia (4 arms), sponsored by Otsuka Pharmaceutical Co., Ltd. Primary endpoint: Percent change in LDL-C from baseline to Week 12. Started Mar 2021; status: completed.
02
Drugs
bempedoic acid
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on jRCT2031200445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031200445.